Exane Derivatives’s Criteo S.A. CRTO Stock Holding History

Exane Derivatives’s Portfolio CRTO Stock Details CRTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1	Closed	-$24	–	694
2018 Q3	$24	Hold	1	–	–	﹤0.01%	670
2018 Q2	$33	Sell	1 -32,921	-100%	-$907K	﹤0.01%	648
2018 Q1	$887K	Sell	32,922 -11,648	-26%	-$316K	0.18%	128
2017 Q4	$1.16M	Sell	44,570 -110,890	-71%	-$3.97M	0.2%	92
2017 Q3	$6.45M	Buy	155,460 +30,816	+25%	+$1.47M	1.21%	17
2017 Q2	$6.11M	Buy	124,644 +16,514	+15%	+$839K	1.31%	12
2017 Q1	$5.4M	Buy	+108,130	New	+$5.06M	1.22%	15
2016 Q1	–	Sell	-237,689	Closed	-$9.41M	–	592
2015 Q4	$9.41M	Buy	237,689 +30,351	+15%	+$1.2M	1.29%	33
2015 Q3	$7.78M	Buy	207,338 +61,642	+42%	+$2.82M	0.98%	34
2015 Q2	$6.95M	Sell	145,696 -13,818	-9%	-$630K	0.75%	38
2015 Q1	$6.3M	Sell	159,514 -143,641	-47%	-$5.98M	0.7%	43
2014 Q4	$12.3M	Buy	+303,155	New	+$10.8M	1.7%	32

Other funds holding CRTO

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

IVA

International Value Advisers $615M AUM 6.37% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bpifrance Maisons Alfort, Cedex, France $1.36B AUM 21.86% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

SMDAM

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Exane Derivatives's CRTO Position: Q4 2018 in Review

Exane Derivatives sold out of Criteo S.A. (CRTO) in Q4 2018, closing a stake of 1 share — an estimated $24 sold.

Exane Derivatives first reported a position in CRTO in Q4 2014 and held it in 12 quarters. The position peaked at $12.3M in Q4 2014. 130 funds tracked by Wall St. Rank hold CRTO as of Q4 2018.

Exane Derivatives reported no remaining Criteo S.A. position as of Q4 2018 after selling out during the quarter.
Exane Derivatives sold 1 Criteo S.A. share in Q4 2018, an estimated $24.
Exane Derivatives first reported a position in Criteo S.A. in Q4 2014 and held it in 12 quarters.
Exane Derivatives's Criteo S.A. position peaked at $12.3M in Q4 2014.
130 funds tracked by Wall St. Rank held Criteo S.A. as of Q4 2018.

Based on Exane Derivatives's 13F filing for Q4 2018, filed 31 Jan 2019.